Skip to content
Fiscal Receipts

Senate LDA lobbying filing

CENCORA, INC.

Registrant: CENCORA, INC. Year: 2024 Period: Fourth Quarter Type: Q4

View on lda.senate.gov ↗

Reported income

not reported

Reported expenses

$1.10M

Tracked program mentions4

Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.

  • Industrial Preparedness/Pol Prevention000042matched: “Preparedness|Preventionmatched 2+ title words

    Strategic National Stockpile. Essential Medicines Strategic Stockpile Act (H.R.405). Prescription Information…

  • Joint Personnel Recovery Agency0901202Fmatched: “Recovery|Agencymatched 2+ title words

    Strategic National Stockpile. Essential Medicines Strategic Stockpile Act (H.R.405). Prescription Information…

  • Making, Maintaining, Supply Chain and Logistics0602025Ematched: “Supply|Chainmatched 2+ title words

    Strategic National Stockpile. Essential Medicines Strategic Stockpile Act (H.R.405). Prescription Information…

  • White House Communication Agency90matched: “House|Agencymatched 2+ title words

    Pharmacy and Medically Underserved Area Enhancement Act (S.1491). Preventing and Mitigating Generic Drug Shortages The…

Lobbying activities4

  • Health IssuesHCR

    Strategic National Stockpile. Essential Medicines Strategic Stockpile Act (H.R.405). Prescription Information Modernization Act (H.R.1503/S.2916). Drug Shortages Pandemic and All Hazards Preparedness Reauthorization and Response Act (legislation). Drug Supply Chain Security Act Implementation (DSCSA). Rolling Active Pharmaceutical Ingredient and Drug (RAPID) Reserve Act (S.2510/H.R.6802). SUPPORT Act Reauthorization (S.2433/H.R.4531). FY2025 National Defense Authorization Act. House E&C Drug Shortages Discussion Draft. FY 2024 Continuing Resolution. Seniors Access to Critical Medications Act of 2023 (H.R. 5526/S.3458) Department of Defense Essential Medicines Strategic Stockpile Amendment to NDAA Health Care Cybersecurity Improvement Act of 2024 (S.4054) Broadening Utilization of Proven and Effective Treatment for Recovery Act or the BUPE for Recovery Act (H.R.9886/S.5271)

  • Medicare/MedicaidMMM

    Proposed modifications to the existing definition of distributor bona fide service fees The Equitable Community Access to Pharmacist Services Act (H.R. 1770/ S.2477) Inflation Reduction Act Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Physician Medicare reimbursement annual fee update. Pharmacy and Medically Underserved Areas Enhancement Act (S.1491). Seniors Access to Critical Medicines Act (H.R. 5526/S.3458). Protecting Patient Access to Cancer and Complex Therapies Act (S. 2764). Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages Senate Finance Draft Medicare Drug Shortage Prevention Policies

  • PharmacyPHA

    Pharmacy and Medically Underserved Area Enhancement Act (S.1491). Preventing and Mitigating Generic Drug Shortages The Equitable Community Access to Pharmacist Services Act (H.R. 1770/S.2477). Seniors Access to Critical Medications Act of 2023 (H.R. 5526/S.3458) House and Senate Agriculture, FDA and related agency Appropriation bills House and Senate Labor/HHS Appropriations bills

  • Taxation/Internal Revenue CodeTAX

    Tax Cuts and Jobs Act of 2017. LIFO accounting method

Lobbyists3

  • DARRELL ROGERS
  • SHELLY MUI-LIPNIK
  • VIVIENNE MITCHELL

Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.